Companies / BOC Sciences / Gemtuzumab
BOC Sciences

Gemtuzumab | BOC Sciences

Gemtuzumab (brand name Mylotarg) is a monoclonal antibody used in the treatment of acute myeloid leukemia (AML). Gemtuzumab targets CD33, a protein found on the surface of myeloid cells, including leukemic cells in AML. By binding to CD33, gemtuzumab may induce antibody-dependent cellular cytotoxicity (ADCC), leading to destruction of CD33-positive leukemia cells. Gemtuzumab is indicated for the treatment of newly diagnosed CD33-positive AML in adults, as well as for relapsed or refractory CD33-positive AML in both adults and pediatric patients.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.